Claritev Total Assets 2019-2025 | CTEV

Claritev total assets from 2019 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Claritev Annual Total Assets
(Millions of US $)
2024 $5,151
2023 $6,965
2022 $7,371
2021 $8,220
2020 $8,284
2019 $8,360
2018 $0
Claritev Quarterly Total Assets
(Millions of US $)
2025-03-31 $5,085
2024-12-31 $5,151
2024-09-30 $5,319
2024-06-30 $5,742
2024-03-31 $6,367
2023-12-31 $6,965
2023-09-30 $7,058
2023-06-30 $7,136
2023-03-31 $7,215
2022-12-31 $7,371
2022-09-30 $8,192
2022-06-30 $8,216
2022-03-31 $8,276
2021-12-31 $8,220
2021-09-30 $8,279
2021-06-30 $8,339
2021-03-31 $8,355
2020-12-31 $8,284
2020-09-30 $1,108
2020-06-30 $1,108
2020-03-31 $1,108
2019-12-31 $0
2018-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.437B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.908B 52.36
Hims & Hers Health (HIMS) United States $12.273B 127.51
Tempus AI (TEM) United States $10.774B 0.00
IRhythm Technologies (IRTC) United States $4.555B 0.00
Inspire Medical Systems (INSP) United States $4.224B 66.00
Privia Health (PRVA) United States $2.787B 190.50
Enovis (ENOV) United States $1.803B 10.05
Clover Health Investments (CLOV) United States $1.623B 0.00
Schrodinger (SDGR) United States $1.563B 0.00
Phreesia (PHR) United States $1.431B 0.00
Omnicell (OMCL) United States $1.322B 23.33
Azenta (AZTA) United States $1.236B 57.45
10x Genomics (TXG) United States $1.006B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.537B 0.00
Veradigm (MDRX) United States $0.476B 0.00
Talkspace (TALK) United States $0.472B 141.00
TruBridge (TBRG) United States $0.357B 791.00
Standard BioTools (LAB) United States $0.350B 0.00
Outset Medical (OM) United States $0.318B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.190B 0.00
EUDA Health Holdings (EUDA) Singapore $0.140B 0.00
Pulmonx (LUNG) United States $0.125B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
CareCloud (CCLD) United States $0.084B 3.21
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00